does semaglutide affect the heart protects beyond weight loss benefits Semaglutide Shows Secondary Cardiovascular Prevention

References Kapoor R, Shome D, Vadera S, Kumar V, Ram MS

By 2030, the market is forecasted to reach USD 289.06 million , contributing USD 46.36 million during the first half of the decade

While Semaglutide offers significant benefits for managing diabetes and weight loss, it may also lead to gastrointestinal issues such as nausea, vomiting, and diarrhea

Since then, the mechanisms and benefits of GLP-1s have become better understood and revealed new opportunities where they could potentially be used in the treatment of additional conditions

Mann JFE, Rossing P, Bakris G et al (2024) Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Krumholz analyzed the problems and worked with people at hospitals around the country to make research-based improvements